176 related articles for article (PubMed ID: 15201463)
1. Assessment of impaired proteasomal function in a cellular model of polyglutamine diseases.
Jana NR; Nukina N
Methods Mol Biol; 2004; 277():287-92. PubMed ID: 15201463
[TBL] [Abstract][Full Text] [Related]
2. Proteasome degrades soluble expanded polyglutamine completely and efficiently.
Michalik A; Van Broeckhoven C
Neurobiol Dis; 2004 Jun; 16(1):202-11. PubMed ID: 15207277
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.
Abu-Baker A; Messaed C; Laganiere J; Gaspar C; Brais B; Rouleau GA
Hum Mol Genet; 2003 Oct; 12(20):2609-23. PubMed ID: 12944420
[TBL] [Abstract][Full Text] [Related]
4. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
Li Z; Arnaud L; Rockwell P; Figueiredo-Pereira ME
J Neurochem; 2004 Jul; 90(1):19-28. PubMed ID: 15198663
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin, proteasomes, and the aging brain.
Gray DA; Tsirigotis M; Woulfe J
Sci Aging Knowledge Environ; 2003 Aug; 2003(34):RE6. PubMed ID: 12944592
[TBL] [Abstract][Full Text] [Related]
6. [The ubiquitin-proteasome system: the relationship between protein degradation and human diseases].
Amir R; Ciechanover A; Cohen S
Harefuah; 2001 Dec; 140(12):1172-6, 1229. PubMed ID: 11789303
[TBL] [Abstract][Full Text] [Related]
7. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.
Jana NR; Zemskov EA; Wang Gh ; Nukina N
Hum Mol Genet; 2001 May; 10(10):1049-59. PubMed ID: 11331615
[TBL] [Abstract][Full Text] [Related]
8. The components of the proteasome system and their role in MHC class I antigen processing.
Krüger E; Kuckelkorn U; Sijts A; Kloetzel PM
Rev Physiol Biochem Pharmacol; 2003; 148():81-104. PubMed ID: 12687403
[TBL] [Abstract][Full Text] [Related]
9. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway.
Jana NR; Nukina N
J Chem Neuroanat; 2003 Oct; 26(2):95-101. PubMed ID: 14599658
[TBL] [Abstract][Full Text] [Related]
11. Pyrrolidine dithiocarbamate and zinc inhibit proteasome-dependent proteolysis.
Kim I; Kim CH; Kim JH; Lee J; Choi JJ; Chen ZA; Lee MG; Chung KC; Hsu CY; Ahn YS
Exp Cell Res; 2004 Aug; 298(1):229-38. PubMed ID: 15242777
[TBL] [Abstract][Full Text] [Related]
12. 20S proteasome mediated degradation of DHFR: implications in neurodegenerative disorders.
Amici M; Sagratini D; Pettinari A; Pucciarelli S; Angeletti M; Eleuteri AM
Arch Biochem Biophys; 2004 Feb; 422(2):168-74. PubMed ID: 14759604
[TBL] [Abstract][Full Text] [Related]
13. Cytosol-endoplasmic reticulum interplay by Sec61alpha translocon in polyglutamine-mediated neurotoxicity in Drosophila.
Kanuka H; Kuranaga E; Hiratou T; Igaki T; Nelson B; Okano H; Miura M
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11723-8. PubMed ID: 14504396
[TBL] [Abstract][Full Text] [Related]
14. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.
Coulombe P; Rodier G; Bonneil E; Thibault P; Meloche S
Mol Cell Biol; 2004 Jul; 24(14):6140-50. PubMed ID: 15226418
[TBL] [Abstract][Full Text] [Related]
15. Taking a bite: proteasomal protein processing.
Rape M; Jentsch S
Nat Cell Biol; 2002 May; 4(5):E113-6. PubMed ID: 11988749
[TBL] [Abstract][Full Text] [Related]
16. Degadration of mismatch repair hMutSalpha heterodimer by the ubiquitin-proteasome pathway.
Hernandez-Pigeon H; Laurent G; Humbert O; Salles B; Lautier D
FEBS Lett; 2004 Mar; 562(1-3):40-4. PubMed ID: 15043999
[TBL] [Abstract][Full Text] [Related]
17. Beyond the Qs in the polyglutamine diseases.
Orr HT
Genes Dev; 2001 Apr; 15(8):925-32. PubMed ID: 11316786
[No Abstract] [Full Text] [Related]
18. Brain proteasomal function in sporadic Parkinson's disease and related disorders.
Furukawa Y; Vigouroux S; Wong H; Guttman M; Rajput AH; Ang L; Briand M; Kish SJ; Briand Y
Ann Neurol; 2002 Jun; 51(6):779-82. PubMed ID: 12112087
[TBL] [Abstract][Full Text] [Related]
19. Hyperphosphorylation of rat liver proteasome subunits: the effects of ethanol and okadaic acid are compared.
Bardag-Gorce F; Venkatesh R; Li J; French BA; French SW
Life Sci; 2004 Jun; 75(5):585-97. PubMed ID: 15158368
[TBL] [Abstract][Full Text] [Related]
20. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders.
Chung KK; Dawson VL; Dawson TM
Trends Neurosci; 2001 Nov; 24(11 Suppl):S7-14. PubMed ID: 11881748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
